Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MRNA | Common Stock | Gift | $0 | -100K | -4.28% | $0.00 | 2.24M | Aug 11, 2021 | Direct | F1 |
holding | MRNA | Common Stock | 6.12M | Dec 31, 2021 | By Flagship Ventures Fund IV, L.P. and Flagship Ventures Fund IV-Rx, L.P. | F2 | |||||
holding | MRNA | Common Stock | 11.5M | Dec 31, 2021 | By Flagship VentureLabs IV LLC and Flagship Pioneering, Inc. | F3 |
Id | Content |
---|---|
F1 | Includes shares received in prior distributions-in-kind from Flagship Ventures Fund IV, L.P. ("Flagship Fund IV") and Flagship Ventures Fund IV-Rx, L.P. ("Flagship Fund IV-Rx") made in accordance with the exemptions afforded by Rule 16a-13 and Rule 16a-9 of the Securities Exchange Act of 1934, as amended. |
F2 | 3,276,339 shares are held directly by Flagship Fund IV and 2,840,318 shares are held directly by Flagship Fund IV-Rx. Flagship Ventures Fund IV General Partners LLC ("Flagship Fund IV GP") is the general partner of each of Flagship Fund IV and Flagship Fund IV-Rx. The reporting person is the sole manager of Flagship Fund IV GP and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |
F3 | 11,460,435 shares are held directly by Flagship VentureLabs IV LLC ("VentureLabs IV") and 3,924 shares are held directly by Flagship Pioneering, Inc. ("Flagship Pioneering"). Flagship Fund IV is a member of VentureLabs IV and also serves as its manager. Flagship Fund IV GP is the general partner of Flagship Fund IV. The reporting person is the sole manager of Flagship Fund IV GP and CEO and sole stockholder of Flagship Pioneering and disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. |